BeOne Medicines
ONC
#642
Rank
A$56.08 B
Marketcap
A$495.82
Share price
2.11%
Change (1 day)
-0.42%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Half-year Reports

Thumbnail BeOne Medicines Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report